Actively Recruiting
Watch-and-Wait Strategy Using Dostarlimab Immunotherapy in Localized dMMRMSI-H Gastric and Gastroesophageal Junction Adenocarcinoma
Led by GERCOR - Multidisciplinary Oncology Cooperative Group · Updated on 2026-08-26
89
Participants Needed
18
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating dostarlimab followed by a watch-and-wait approach in patients with localized deficient mismatch repair dMMR or microsatellite instability-high MSI-H gastric or gastroesophageal junction adenocarcinoma. The study aims to see if surgery can be safely avoided in patients who achieve a complete response, defined by negative endoscopy and tumor-free biopsies after the treatment. This phase II, national, multicenter, open-label study includes a main cohort and an additional group of patients unfit for surgery. Participants will receive dostarlimab at 500 mg intravenously every three weeks for four cycles. After these initial cycles, treatment is adapted based on clinical assessment, including possible continuation of dostarlimab or surgery depending on tumor response. For patients achieving complete response, a watch-and-wait strategy is followed. Those unfit for surgery receive dostarlimab with monitoring but may stop treatment if disease progression occurs. During the study, participants undergo regular evaluations including endoscopy with biopsies, CT scans, and tumor assessments to monitor response and detect recurrence. Researchers will measure clinical and pathological complete responses, survival outcomes, disease progression, adverse events, and quality of life over up to five years. The goal is to assess if surgery can be omitted safely and to monitor long-term effects and patient well-being throughout the study period.
CONDITIONS
Brief Title
DEWI: Watch-and-Wait With Dostarlimab in Localized dMMR/MSI-H Gastric/GEJ Adenocarcinoma Phase II Study
Research Team
M
Marie-Line GARCIA LARNICOL, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here